Medium term health coaching and life-long monitoring in cardiovascular
Who is the patient population?
In cluster 6, the targeted patient population is persons with diagnoses of ischemic heart disease.
What characterises the interventions?
The details of the telemedicine interventions and the technologies used differ between the regions. Detailed information at regional level can be found in specific area.
However, all interventions in Cluster 6 are characterised by the following:
- Implementing and assessing short-term follow-up interventions in randomised controlled trials
- Aim to increase the health related quality of life, health status and empowerment of patients with a ischemic heart disease.
- Offer synchronic or asynchrony person centred communication between patient and health professional through PC:s, IPads or Mobil phones.
- Remote monitoring and transmission of measurements (blood pressure, pulse, weight)
- In parallel evaluate the economic and organisational impact of the interventions, and examine the user acceptability of the telemedicine applications (both patients and professionals).
What are the expected results at cluster level?
The result will - part from individual trial assessments using MAST - be a meta-analysis which calculates the overall effects at cluster level within all aspects of MAST. Also, it will investigate causes for possible differences between regions and thus provide valuable knowledge and documentation for short-term telemedicine intervention for persons with ischemic heart disease based on the data from three regional trials.
Which regions participate?
County Council of Norrbotten - Sweden
Timing
| Start of trial/inclusion of patients | Inclusion complete* | Follow-up period ended | Expected time of publishing of results* | |
| Norrbotten | February 2011 | September 2011 | September 2012 | During 2013 |
| South Karelia | February 2011 | January 2012 | December 2012 | During 2013 |
*Please note that these are estimates and are subject to change as the trial progress.